GAIN THERAPEUTICS, INC (GANX) Total liabilities 2021–2024
GAIN THERAPEUTICS, INC (GANX) total liabilities at each fiscal year-end, per SEC filings.
$6.0MFY2024 · since FY2021: $3.4M → $6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $6.0M | +15.5% |
| FY2023 | $5.2M | +25.3% |
| FY2022 | $4.2M | +22.5% |
| FY2021 | $3.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GANX financial trends
GANX RevenueGANX Net incomeGANX Net marginGANX Gross profitGANX Gross marginGANX Operating incomeGANX Operating marginGANX Operating cash flowGANX Free cash flowGANX Capital expendituresGANX Return on equityGANX Stock buybacksGANX Dividends paidGANX Total assetsGANX Shareholders’ equityGANX overview →